A carregar...
DIPG-72. TARGETING MULTIPLE PATHWAYS AS A TREATMENT STRATEGY IN DIFFUSE MIDLINE GLIOMA
BACKGROUND: Diffuse midline glioma (DMG) is an entity characterized by midline location, treatment refractoriness, short survival, and H3 histone mutation. DMG encompasses pediatric diffuse intrinsic pontine glioma (DIPG), as most (80%) harbor an H3 mutation as well. REPURPOSED DRUG THERAPY: DMGs re...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012039/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.164 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|